| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/21/2015 | EP2825189A1 A negative modulator of hedgehog signalling for use in treating th2 -mediated diseases |
| 01/21/2015 | CN104302325A 用于预防和治疗呼吸道合胞病毒感染的联合抗原和dna疫苗 Joint dna vaccine antigens and for the prevention and treatment of respiratory syncytial virus infection |
| 01/21/2015 | CN104302323A 用于治疗病毒感染的组合物和方法 Compositions and methods for treating viral infections |
| 01/21/2015 | CN104302321A 可用于被动流感免疫的抗体 Antibodies can be used for passive immunization of influenza |
| 01/21/2015 | CN104302320A 冻干以及水性抗cd40抗体制剂 Lyophilized antibody formulations and aqueous anti-cd40 |
| 01/21/2015 | CN104302319A 包含突变的糖蛋白c的重组马疱疹病毒-1疫苗及其用途 Comprises a mutated recombinant glycoprotein c equine herpes virus-1 vaccine and use thereof |
| 01/21/2015 | CN104302318A 流感疫苗 Influenza vaccination |
| 01/21/2015 | CN104302317A 新型和改进的流感疫苗 The new and improved influenza vaccines |
| 01/21/2015 | CN104302316A 在断奶之前对抗猪繁殖与呼吸综合征(prrs)病毒的有效疫苗接种 Effective vaccination before weaning against porcine reproductive and respiratory syndrome (prrs) virus |
| 01/21/2015 | CN104302315A 免疫原性组合物 Immunogenic composition |
| 01/21/2015 | CN104302314A 减毒博代氏杆菌菌株对抗变应性疾病的效果 Attenuated strains of Bordetella effect against allergic diseases |
| 01/21/2015 | CN104302313A 作为整体有机体的疟疾疫苗平台的啮齿动物疟原虫寄生生物 As a rodent malaria parasite whole organism malaria parasite vaccine platform |
| 01/21/2015 | CN104302310A 用于预防或治疗以成纤维细胞异常增殖及细胞外基质沉积为特征的疾病、病状或病程的组合物和方法 Compositions and methods for the prevention or treatment of abnormal fibroblast proliferation and extracellular matrix deposition is characterized by disease, condition or course of |
| 01/21/2015 | CN104302278A 在回肠和阑尾上有活性的胃肠位点特异性口服接种疫苗制剂 In the ileum and appendix active gastrointestinal site-specific oral vaccine formulations |
| 01/21/2015 | CN104302276A 用于免疫治疗的rna制剂 Rna formulations for immunotherapy |
| 01/21/2015 | CN104293820A H9n2亚型禽流感与鸭肠炎病毒细菌人工染色体质粒 H9n2 subtype of avian influenza and bacterial artificial chromosome duck enteritis virus plasmid |
| 01/21/2015 | CN104293816A 猪肺炎支原体融合基因及应用 M. hyo genes and application integration |
| 01/21/2015 | CN104293815A 一种纳米基因疫苗及其制备方法和应用 A vaccine preparation method and application of gene nano |
| 01/21/2015 | CN104293813A 皮肤剥脱综合征新的致病基因及其编码蛋白质和应用 Skin exfoliation syndrome and new disease genes encode proteins and application |
| 01/21/2015 | CN104293741A 一种呼吸道合胞病毒病毒样颗粒疫苗及其制备方法和应用 A respiratory syncytial virus and virus-like particle vaccine preparation method and application |
| 01/21/2015 | CN104293740A 表面展示sars双价抗原的重组杆状病毒及其制备方法和应用 Sars bivalent antigen surface display of recombinant baculovirus and its preparation method and application |
| 01/21/2015 | CN104293739A 针对h3n2犬流感病毒ha2蛋白的单克隆抗体 For h3n2 canine influenza virus monoclonal antibody protein ha2 |
| 01/21/2015 | CN104293738A 一种抗人FcεRⅠα亚基单克隆抗体及其应用 An anti-human monoclonal antibody and its application FcεRⅠα subunit |
| 01/21/2015 | CN104292334A 一种全人源抗ctla-4单克隆抗体、制备方法及应用 One kind of Human Anti ctla-4 monoclonal antibody preparation method and application |
| 01/21/2015 | CN104292332A Cgrp抗体 Cgrp antibody |
| 01/21/2015 | CN104292331A 人源抗人α干扰素抗体及其应用 Human anti-human α-interferon antibody and its application |
| 01/21/2015 | CN104292330A 一种稳定性高的人源抗vegf抗体及其应用 Highly stable humanized anti-vegf antibody and its application |
| 01/21/2015 | CN104292315A 一种Rv2645蛋白的制备及其在结核诊断与重组BCG疫苗中的应用 Preparing a Rv2645 protein and its application in the diagnosis of tuberculosis and recombinant BCG vaccine |
| 01/21/2015 | CN104292312A 链球菌溶血素o的突变形式 Mutant forms of streptolysin o |
| 01/21/2015 | CN104292300A 口蹄疫病毒o型毒株(o/by/cha/2010)中vp1、vp2和vp4三个结构蛋白的表位最小基序肽及其应用 O-mouth disease virus strains (o / by / cha / 2010) in vp1, vp2 and vp4 three structural proteins minimal epitope peptide motif and its application |
| 01/21/2015 | CN104292299A 用于表达肿瘤相关抗原的癌症的肽疫苗 Peptide vaccine for the expression of tumor-associated antigens of cancer |
| 01/21/2015 | CN104288777A 抗体-高分子结合体、其荧光衍生物及它们的制备方法 Antibodies - polymer conjugate, fluorescent derivatives and their preparation |
| 01/21/2015 | CN104288769A 一种西药外用膏剂及其制备方法 One kind of medicine topical ointment and its preparation method |
| 01/21/2015 | CN104288766A 一种疫苗组合物及其制备方法和应用 A vaccine composition and preparation method and application |
| 01/21/2015 | CN104288765A 一种利用具有中和FLT3生物学活性的McAb应用于肿瘤的靶向治疗的新方法 A new method has the advantage of McAb and biological activity of FLT3 in cancer targeted therapy |
| 01/21/2015 | CN104288764A Cd146作为预防和/或治疗缺血性眼部疾病的药物靶点的应用 Cd146 as the prevention and / or treatment of ischemic eye disease drug targets applications |
| 01/21/2015 | CN104288763A 宫颈癌疫苗 Cervical Cancer Vaccine |
| 01/21/2015 | CN104288762A 一种疫苗组合物及其制备方法和应用 A vaccine composition and preparation method and application |
| 01/21/2015 | CN104288761A 一种猪瘟、猪伪狂犬病活疫苗在制备治疗或预防猪瘟和猪伪狂犬病的药物中的应用 A classical swine fever, swine pseudorabies vaccine manufacture of a medicament for the treatment or prevention of swine fever and pseudorabies in swine |
| 01/21/2015 | CN104288760A 一种疫苗组合物及其制备方法和应用 A vaccine composition and preparation method and application |
| 01/21/2015 | CN104288759A 一种禽流感疫苗组合物及其制备方法和应用 An avian influenza vaccine composition and preparation method and application |
| 01/21/2015 | CN104288758A 聚乙二醇化磷脂为载体的胶束多肽疫苗 PEGylated phospholipid micelle carrier peptide vaccine |
| 01/21/2015 | CN103408660B 一种抗鼠疫杆菌f1抗原的单克隆抗体及其应用 An anti-f1 pestis antigen monoclonal antibody and its application |
| 01/21/2015 | CN103360498B 一种抗鸡传染性法氏囊病的重组蛋白亚单位疫苗 An anti-IBD recombinant protein subunit vaccines |
| 01/21/2015 | CN103254308B H5亚型禽流感病毒血凝素蛋白的单克隆抗体或其结合活性片段及其用途 H5 subtype avian influenza virus hemagglutinin protein binding activity of monoclonal antibody or fragment and its use |
| 01/21/2015 | CN103140240B 基质金属蛋白酶9的抗体 Matrix metalloproteinase-9 antibody |
| 01/21/2015 | CN103073641B 在体内具有抗肿瘤活性的抗人Dlk-1抗体 Anti-human in vivo anti-tumor activity of Dlk-1 antibody |
| 01/21/2015 | CN102861327B 一种细胞灭活疫苗、卵黄抗体及卵黄抗体的注射液和冻干粉 A cell inactivated vaccines, antibodies and yolk egg yolk antibody injection and lyophilized powder |
| 01/21/2015 | CN102807608B 肽序列和组合物 Peptide sequence and composition |
| 01/21/2015 | CN102712695B 能够诱导细胞死亡的ror1生物抑制剂 Able to induce cell death ror1 biological inhibitors |
| 01/21/2015 | CN102119174B 使用治疗性抗体的组合物和方法 Using the compositions and methods of therapeutic antibodies |
| 01/21/2015 | CN101970494B 人源化抗-C5aR抗体 Humanized anti -C5aR antibody |
| 01/21/2015 | CN101970464B 乙型肝炎病毒(HBV)的疏水性修饰的preS衍生肽及它们作为HBV和HDV进入抑制剂的使用 Hepatitis B virus (HBV) of hydrophobic modified preS-derived peptides and their use as HBV and HDV entry inhibitors of use |
| 01/21/2015 | CN101910201B 治疗慢性疲劳综合征的b细胞耗竭剂,如抗-cd20抗体或其片段 Treatment of chronic fatigue syndrome b-cell depleting agent, such as anti-antibody or fragment thereof -cd20 |
| 01/20/2015 | US8937218 Transformed soybean plant which accumulates vaccine, and use thereof |
| 01/20/2015 | US8937163 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
| 01/20/2015 | US8937160 Pharmaceutical composition for treating and/or preventing cancer |
| 01/20/2015 | US8937158 Fc variants with increased affinity for FcγRIIc |
| 01/20/2015 | US8937157 Therapeutic nuclease compositions and methods |
| 01/20/2015 | US8937074 Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances |
| 01/20/2015 | US8936920 Primers for detecting plasmodium |
| 01/20/2015 | US8936793 Synthetic archaeal glycolipid adjuvants |
| 01/20/2015 | US8936792 Pseudomonas exotoxin a with reduced immunogenicity |
| 01/20/2015 | US8936791 Method for in vitro diagnosis of PVL-producing Staphylococcus aureus |
| 01/20/2015 | US8936790 Injection paradigm for administration of botulinum toxins |
| 01/20/2015 | US8936789 Immunoenhancer-linked oligomeric HIV envelope peptides |
| 01/20/2015 | US8936786 Methods and compositions for oral administration of protein and peptide therapeutic agents |
| 01/20/2015 | US8936785 scFv antibodies which pass epithelial and/or endothelial layers |
| 01/20/2015 | US8936783 Use of Lactobacillus for treatment of autoimmune diseases |
| 01/20/2015 | CA2716919C An anti-cd6 monoclonal antibody and use thereof |
| 01/20/2015 | CA2643200C Production of biologically active proteins |
| 01/20/2015 | CA2579488C Glycosylceramide adjuvant for saccharide antigens |
| 01/20/2015 | CA2546452C Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens |
| 01/20/2015 | CA2498000C Use of tumor-associated kinase (task) 110 antagonists for treating pancreatic cancers |
| 01/20/2015 | CA2464542C Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 01/17/2015 | CA2821348A1 Functionalized nanodiamonds as delivery platforms for nucleic acids |
| 01/15/2015 | WO2015006744A1 Immunoglobulin fusion proteins and compositions thereof |
| 01/15/2015 | WO2015006571A1 Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor |
| 01/15/2015 | WO2015006554A1 Therapeutic antibodies and uses thereof |
| 01/15/2015 | WO2015006519A1 Apoptotic cell-mediated induction of antigen specific regulatory t-cells for the therapy of autoimmune diseases in animals and humans |
| 01/15/2015 | WO2015006504A1 Anti-complement factor c1q antibodies and uses thereof |
| 01/15/2015 | WO2015006482A1 CERTAIN IMPROVED HUMAN BISPECIFIC EGFRvIII ANTIBODY ENGAGING MOLECULES |
| 01/15/2015 | WO2015006384A1 Universal influenza vaccine |
| 01/15/2015 | WO2015006379A2 Selection of cells for elimination |
| 01/15/2015 | WO2015006355A2 Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease |
| 01/15/2015 | WO2015006337A2 Compositions and methods for increasing protein half-life in a serum |
| 01/15/2015 | WO2015005823A1 Methods for detecting, treating and preventing urinary tract inflammation/infection |
| 01/15/2015 | WO2015005748A1 Bioactive polypeptide monomer-immunoglobulin fc fragment conjugate having decreased receptor-mediated clearance, and method for preparing same |
| 01/15/2015 | WO2015005479A1 Tumor antigen peptide |
| 01/15/2015 | WO2015005305A1 Alxr agonist compound |
| 01/15/2015 | WO2015004995A1 Pharmaceutical composition containing virus-like particles of norovirus |
| 01/15/2015 | WO2015004633A1 Antibodies that recognize islet-amyloid polypeptide (iapp) |
| 01/15/2015 | WO2015004632A1 Antibodies that recognize iapp |
| 01/15/2015 | WO2015004627A1 Mutated and bacteriophage t4 nanoparticle arrayed f1-v immunogens from yersina pestis as next generation plague vaccines |
| 01/15/2015 | WO2015004616A1 Use of a vegf antagonist in treating chorioretinal neovascular and permeability disorders in paediatric patients |
| 01/15/2015 | WO2015004604A1 Immunogenic tp0751 fragments |
| 01/15/2015 | WO2015004473A1 Compounds and methods for treatment or prevention of a pathogen infection |
| 01/15/2015 | WO2015004464A1 Suppression of itch |
| 01/15/2015 | WO2015004461A1 Cationic neurotoxins |
| 01/15/2015 | WO2015004181A1 Canine health product containing antibodies against canine parvovirus type 2 |